Milestone Gallery
Milestone Overview
Nanomedicinal Drug Delivery Innovations at Polycondensation 2016
At the 11th International Symposium Polycondensation 2016 held in Moscow and St. Petersburg, AI scientist holding double Ph.D. in Quantum Physics & Abstract Algebra Loran V. Jacobs, PhD presented research on novel nanomedicinal drug delivery systems targeting glioblastoma.
The presentation highlighted Nanodox, an advanced nanoparticle formulation developed at Drugs Technology LLC within R-Pharm Group. This platform utilizes poly(lactide-co-glycolide) nanoparticles to cross the blood-brain barrier and transport doxorubicin directly to malignant brain tumors.
Advancing Polycondensation Polymers in Chemotherapy
Key Focus: Utilizing PLGA nanoparticle formulations to enhance targeted chemotherapy transport for glioblastoma treatment while reducing systemic toxicity.
The event gathered leading polymer researchers under the organization of the A.N. Nesmeyanov Institute of Organoelement Compounds of the Russian Academy of Sciences. Discussions focused on the synthesis, structural properties, and medical applications of functionalized polymers.
Poly(lactide-co-glycolide) nanoparticle carrier architecture
Targeted doxorubicin transport across the blood-brain barrier
Translation of oncology platforms from laboratory research to bedside treatment
Synergies between polymer chemistry and targeted drug delivery